Amentoflavone
| |
| Names | |
|---|---|
| IUPAC name
8-[5-(5,7-Dihydroxy-4-oxo-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
| |
| Other names
Didemethyl-ginkgetin
3′,8′′-Biapigenin | |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C30H18O10 | |
| Molar mass | 538.464 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Amentoflavone is a biflavonoid (bis-apigenin coupled at 8 and 3' positions, or 3′,8′′-biapigenin) constituent of a number of plants including Ginkgo biloba, Chamaecyparis obtusa (hinoki), Hypericum perforatum (St. John’s Wort)[1] and Xerophyta plicata.[2]
Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body.[3] It is also an inhibitor of human cathepsin B.[1]
Amentoflavone has a variety of in vitro activities including antimalarial activity,[4] anticancer activity (which may, at least in part, be mediated by its inhibition of fatty acid synthase),[5][6][7] and antagonist activity at the κ-opioid receptor (Ke = 490 nM)[8] as well as activity at the allosteric benzodiazepine site of the GABAA receptor as a negative allosteric modulator.[9]
See also
References
- ^ a b Pan X, Tan N, Zeng G, Zhang Y, Jia R (October 2005). "Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B". Bioorg. Med. Chem. 13 (20): 5819–25. doi:10.1016/j.bmc.2005.05.071. PMID 16084098.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Williams, Christine A.; Harborne, Jeffrey B.; Tomas-Barberan A., Francisco (1987). "Biflavonoids in the primitive monocots Isophysis tasmanica and Xerophyta plicata". Phytochemistry. 26 (9): 2553. doi:10.1016/S0031-9422(00)83875-3.
- ^ Kimura, Y; Ito, H; Ohnishi, R; Hatano, T (January 2010). "Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity". Food Chemistry Toxicology. 48 (1): 429–35. doi:10.1016/j.fct.2009.10.041. PMID 19883715.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ "Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP)".
- ^ Lee, JS; Lee, MS; Oh, WK; Sul, JY (August 2009). "Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells" (PDF). Biological & Pharmaceutical Bulletin. 32 (8): 1427–1432. doi:10.1248/bpb.32.1427. PMID 19652385.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Wilsky, S; Sobotta, K; Wiesener, N; Pilas, J; Althof, N; Munder, T; Wutzler, P; Henke, A (February 2012). "Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication". Archives of Virology. 157 (2): 259–269. doi:10.1007/s00705-011-1164-z. PMID 22075919.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Lee, JS; Sul, JY; Park, JB; Lee, MS; Cha, EY; Song, IS; Kim, JR; Chang, ES (May 2013). "Fatty Acid Synthase Inhibition by Amentoflavone Suppresses HER2/neu(erbB2) Oncogene in SKBR3 Human Breast Cancer Cells". Phytotherapy Research. 27 (5): 713–720. doi:10.1002/ptr.4778. PMID 22767439.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Katavic PL, Lamb K, Navarro H, Prisinzano TE. (August 2007). "Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships". J Nat Prod. 70 (8): 1278–82. doi:10.1021/np070194x. PMC 2265593. PMID 17685652.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Hanrahan, JR; Chebib, M; Davucheron, NL; Hall, BJ; Johnston, GA (2003). "Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors". Bioorganic & Medicinal Chemistry Letters. 13 (14): 2281–4. doi:10.1016/s0960-894x(03)00434-7. PMID 12824018.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |